Sort
27,075 grants matching “cholesterol”
Role of FXR in Renal Disease of Metabolic Syndrome and Aging
$296,743Moshe Levi · University Of Colorado Denver · R01 · FY2010 · AG
Ovarian Androgen Production and Control of Follicular Funtion
$296,720Jairam K Menon · University Of Michigan At Ann Arbor · R01 · FY2010 · HD
12/15-Lipoxygenase and Diabetic Neuropathy
$296,647Irina G Obrosova · Lsu Pennington Biomedical Research Ctr · R01 · FY2008 · DK
12/15-Lipoxygenase and Diabetic Neuropathy
$296,647Irina G Obrosova · Lsu Pennington Biomedical Research Ctr · R01 · FY2009 · DK
NIEMANN-PICK C AND INTRACELLULAR CHOLESTEROL TRANSPORT
$296,625Mount Sinai School Of Medicine Of Nyu · R01 · FY2002 · DK
NIEMANN-PICK C AND INTRACELLULAR CHOLESTEROL TRANSPORT
$296,625Mount Sinai School Of Medicine Of Nyu · R01 · FY2000 · DK
NIEMANN-PICK C AND INTRACELLULAR CHOLESTEROL TRANSPORT
$296,625Mount Sinai School Of Medicine Of Nyu · R01 · FY2001 · DK
NIEMANN-PICK C AND INTRACELLULAR CHOLESTEROL TRANSPORT
$296,625Mount Sinai School Of Medicine Of Nyu · R01 · FY2004 · DK
NIEMANN-PICK C AND INTRACELLULAR CHOLESTEROL TRANSPORT
$296,625Mount Sinai School Of Medicine Of Nyu · R01 · FY2003 · DK
Family Meals as a Strategy for the Primary Prevention of Cardiovascular Disease in Children
$296,612Shannon Marie Robson · University Of Delaware · P20 · FY2023 · GM
** AWARDS ISSUED PRIOR TO JANUARY 20, 2025, WERE FUNDED UNDER PREVIOUS ADMINISTRATIONS AND MAY NOT REFLECT THE PRIORITIES AND POLICIES OF THE CURRENT ADMINISTRATION.** NON-TECHNICAL SUMMARY OBESITY HAS BECOME A WORLDWIDE PROBLEM GIVING RISE TO SERIOUS HEALTH ISSUES SUCH AS HYPERTENSION, TYPE-2 DIABETES, CARDIOVASCULAR DISEASES, AND CERTAIN TYPES OF CANCER. ONE THIRD OF THE ADULT POPULATION IN THE US IS OBESE AND 17% OF CHILDREN SUFFER FROM OBESITY. FUCOXANTHIN, A MARINE CAROTENOID WITH ANTI-OBESITY ACTIVITY, HAS POTENTIAL APPLICATION AS A BIOFUNCTIONAL INGREDIENT IN FOOD. THE OBJECTIVE OF THIS STUDY IS TO EVALUATE THE ANTI-OBESITY EFFECT OF FUCOXANTHIN, WHEN SUPPLEMENTED INTO GOAT MILK YOGURT, ON WEIGHT LOSS IN OVERWEIGHT AND OBESE ADULTS. YOGURT TREATMENTS WILL BE SUPPLEMENTED WITH FUCOXANTHIN AT DIFFERENT CONCENTRATIONS (7.5 MG, 11.5 MG, OR 15.5 MG/170 G CUP OF YOGURT), AND THE CONTROL YOGURT (170 G/CUP) WILL HAVE NO FUCOXANTHIN. THE YOGURT MIXES WILL BE HEATED AT 80°C FOR 30 MIN, THEN COOLED TO 42°C, INOCULATED WITH STREPTOCOCCUS THERMOPHILUS AND LACTOBACILLUS BULGARICUS AT 2%, AND INCUBATED UNTIL PH REACHES 4.3- 4.5 (USUALLY IN 5 H). THE PHYSICOCHEMICAL CHARACTERISTICS OF YOGURTS AND THE QUANTITY OF FUCOXANTHIN IN TREATMENTS WILL BE ANALYZED. SEVENTY-TWO VOLUNTEERS, AGES 23-60 YEARS, WITH A BODY MASS INDEX (BMI) OF 25-40 KG/M2 WILL BE RECRUITED FOR THIS CLINICAL STUDY. THE SUBJECTS WILL BE GIVEN ONE SERVING OF CONTROL OR EXPERIMENTAL YOGURT PER DAY FOR 12 WEEKS. THE ANTHROPOMETRIC INDICES (BODY WEIGHT, HEIGHT, BMI, WAIST CIRCUMFERENCE, AND HIP CIRCUMFERENCE), BODY COMPOSITION, AND LIPID PROFILE (TRIGLYCERIDES, TOTAL CHOLESTEROL, HDL, AND LDL) OF THE SUBJECTS WILL BE MEASURED. COMPARISON OF DATA BEFORE THE INITIATION OF THE STUDY AND AFTER THE INGESTION OF CONTROL AND TREATED YOGURTS WILL ELUCIDATE THE ANTI-OBESITY EFFECT OF FUCOXANTHIN ON HUMAN SUBJECTS. THE DEVELOPMENT OF HEALTHY FOODS TO BETTER SERVE THE NUTRITIONAL NEEDS OF SOCIETY IS IN LINE WITH THE USDA PRIORITY AREA OF DIET, NUTRITION AND PREVENTION OF CHRONIC DISEASES (A1344).
$296,561Prairie View A&M University · · FY2024 · National Institute of Food and Agriculture
Macrophage Cholesterol Efflux During Inflammation
$296,509Nancy R Webb · University Of Kentucky · P01 · FY2008 · HL
Analysis of new compounds to treat familial hypercholesterolemia
$296,495Stephen A Duncan · Gruthan Bioscience Llc · R41 · FY2020 · HL
Macrophage Cholesterol Efflux During Inflammation
$296,485Nancy R Webb · University Of Kentucky · P01 · FY2009 · HL
Mechanisms of apoptotic calcium signaling
$296,485Darren F Boehning · University Of Texas Med Br Galveston · R01 · FY2013 · GM
Brain lipids changes in controlled Cortical impact
$296,475Amina Woods · National Institute On Drug Abuse · ZIA · FY2017 · DA
Molecular Mechanisms of Lung Surfactant Secretion
$296,465Lin Liu · Oklahoma State University Stillwater · R01 · FY2006 · HL
GENISTEIN INDUCES ENDOCRINE-RESISTANCE IN BREAST TUMORS
$296,452William G. Helferich · University Of Illinois At Urbana-Champaign · P01 · FY2008 · AG
Lipidomic, biophysical, and functional differentiation of Mesenchymal Stem Cell membranes
$296,450Ilya Levental · University Of Texas Hlth Sci Ctr Houston · R01 · FY2016 · GM
Lipidomic, biophysical, and functional differentiation of Mesenchymal Stem Cell membranes
$296,450Ilya Levental · University Of Texas Hlth Sci Ctr Houston · R01 · FY2019 · GM
Lipidomic, biophysical, and functional differentiation of Mesenchymal Stem Cell membranes
$296,450Ilya Levental · University Of Texas Hlth Sci Ctr Houston · R01 · FY2015 · GM
Amyloidogenic Processing of APP
$296,444Gopal Thinakaran · University Of Chicago · R01 · FY2010 · AG
HDL and Vascular Injury in Type 2 Diabetes
$296,421C Roger White · University Of Alabama At Birmingham · R01 · FY2008 · DK
Pregnancy complications, future cardiovascular disease risk factors and cardiovas
$296,411Nisha Indravadan Parikh · Queen'S Medical Center · R21 · FY2013 · HL
Cholesterol and the Amyloid Precursor Protein
$296,400Charles R Sanders · Vanderbilt University · R01 · FY2013 · GM